October 2020 - Page 5 of 6 - BioMedWire (BMW)

FridayOct 09, 2020 11:15 am

Early Morning Coffee Could Impair Metabolism, New Research Suggests

October 1st was International Coffee Day, and it is estimated that half of all U.S. adults consume coffee on a daily basis. You might therefore be no stranger to taking a strong cup of coffee each time you wake up feeling groggy. But, did you know that the early morning cup of strong coffee you take could be compromising your metabolism and making it harder for your blood glucose level to be regulated? New research done at the University of Bath (UK) strongly suggests that this is the case. The research team headed by Harry Smith performed overnight experiments on…

FridayOct 09, 2020 9:00 am

Analysis Uncovers a Link Between Obesity & Food Insecurity

Over the years, obesity has become a pressing issue in the U.S., with nearly 30% of Americans afflicted by the condition. Although the assumption is that extreme weight gain is usually caused by binge eating, a variety of factors are usually at play. One such factor is food insecurity, which is defined as the lack of access to enough food for an active, healthy life. Internationally, food insecurity is usually caused by the frequency of conflict as well as the climate-related failure of harvests but in the U.S., it is most often due to limited financial resources. According to a…

ThursdayOct 08, 2020 2:00 pm

Seasonal Colds Could Offer Protection Against COVID-19

Months after the coronavirus sprang onto the global arena and claimed a million lives worldwide, scientists are still scrambling to find a vaccine and ultimately, a cure. At the moment, there are around 40 different coronavirus vaccines in clinical trials, with about 240 vaccines in early development. One such study suggests that we may not even need an external vaccine after all and provides evidence that the seasonal colds you’ve had in the past could offer you protection against COVID-19. On top of that, such immunity to the coronavirus may last a long time, maybe even your entire life, infectious…

WednesdayOct 07, 2020 1:45 pm

Heading Soccer Balls Causes More Damage to Females than Males

Today, it is common to see members of a female soccer team training close to the ground that is being used by their male counterparts, and this is pleasing given how far society has come before accepting that females can participate in contact sports. However, lots of sports scientists noticed that females were complaining more about the effects of heading the ball when compared to their male counterparts. It now turns out that there is a scientific reason for that as explored below. According to a study that was led by Dr. Michael Lipton, a neuroscientist based at the Albert…

WednesdayOct 07, 2020 9:30 am

Pioneer Research Unveils Electronic Skin That Can Feel Pain

Researchers from RMIT University in Australia have created an artificial skin that electronically reacts to pain stimuli like human skin. This has paved the way for intelligent robotics and far better prosthetics to be developed as well as the development of alternative skin grafts which are non-invasive. The prototype device imitates the body’s instant feedback response and reacts with the same speed as the nerve signals would when they travel to the human brain. Madhu Bhaskaran, a professor who is also the lead researcher, stated that the prototype was a remarkable advancement towards intelligent robotics and future biomedical technologies. He…

TuesdayOct 06, 2020 1:15 pm

Georgia Scientists Receive Grant to Improve Mood Disorder Treatment Tool

A team of Georgia State scientists has received a two-year grant to further develop a tool to help psychiatrists better diagnose and treat mood disorders. The $875,110 grant was provided by the National Institute of Mental Health and it will fund studies that will make it easier for mental health professionals to quickly diagnose and treat mental health conditions with accuracy. The researchers are based at the Center for the Translational Research in Neuroimaging and Data Science (TReNDS). TReNDS is a tri-institutional effort supported by Georgia State University, Georgia Institute of Technology, and Emory University that is focused on making…

TuesdayOct 06, 2020 12:53 pm

Processa Pharmaceuticals Inc. (NASDAQ: PCSA) is “One to Watch”

Processa Pharmaceuticals aims to develop products where existing clinical evidence of efficacy already exists in the targeted unmet medical need condition with the drug itself or a drug with very similar pharmacology The Processa process focuses on the advancement of drugs that are ready for clinical development or have minimal pre-IND enabling studies to complete Processa’s current development pipeline features multiple clinical drug candidates, given the recent acquisitions of three additional development-focused licensing agreement since June 2020 In total, the company’s combined scientific, development and regulatory experience has resulted in more than 30 drug approvals by the U.S. Food and…

TuesdayOct 06, 2020 10:00 am

Fecal Transplants Can Rebalance the Microbiota of Infants Born by C-Section

The human gastrointestinal tract has a diverse population of microorganisms, especially bacteria, fungi, and viruses. These are collectively referred to as the microbiota. Some of these colonies are passed on from mother to child during birth through the vaginal canal. However, babies who are born by cesarean section miss out on this microbiota transfer, and that puts their long-term health at risk since they will be more susceptible to immune-related complications later in life. Now a team of researchers has discovered that a mother’s microbiota can be transferred to an infant after birth through a procedure called fecal microbiota transplantation…

MondayOct 05, 2020 12:52 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Partnership with Imaging Specialists IAG Gives Tech Boost to Upcoming Brain Cancer Drug Trials

Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of Berubicin later this year or in Q1 of 2021, building on promising results shown in initial trials One patient in the Phase I trial has remained cancer-free over the course of 14 years, and 44 percent of the patients who could be evaluated experienced a clinically significant positive response to Berubicin CNS’s laser-focused strategy for developing a GBM therapy is also leading the company to…

MondayOct 05, 2020 12:00 pm

Laser-Welded Sugar: The New Technique to Repair Damaged Blood Vessels?

A study that was published in the Nature Biomedical Engineering journal by Rice University bioengineers demonstrated how the researchers created blood vessel networks from 3D-printed sugar templates which they used to keep tightly packed cells alive for a 2-week period. Ian Kinstlinger, who is the lead author of the study, said that among the biggest obstacles in developing clinically significant tissues was trying to provide enough nutrients and oxygen to all the millions of living cells in a large tissue structure. He explained that the development of new materials and technologies that mimic vascular networks that occur naturally had significantly…